1. Fernandez-Balsells MM, Barwise A, Gallegos-Orozco J, Paul A et al. The natural history of pituitary incidentalomas: a systematic review and meta-analysis. J Clin endocrinol Metab. 2011, 96(4):905-12
2. Feldkamp J, Santen R, Harms E, Aulich A et al. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone- secreting adenomas—results of a prospective study. Clin endocrinol (Oxf). 1999. 51:109-113
3. Arita K, Tominaga A, Sugiyama K, Eguchi K et al. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-upexamination. J neurosurg. 2006.104:884-891
4. Sanno N, Oyama K, Tahara S, Teramoto A et al. A survey of pituitary incidentaloma in Japan. Eur J. endocrinol. 2003 149:123-127
5. Fainstein Day P, Guitelman M, Artese R, Fiszledjer L et al. Retrospective multicentric study of pituitary incidentalomas. Pituitary. 2004. 7:145-148
6. Reincke M, Allolio B, Saeger W, Menzel J et al. The ‘incidentaloma’ of the pituitary gland. is neurosurgery required? JAMA. 1990. 263:2772-2776
7. Donovan LE, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med. 1995. 155:181-183
8. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999 Mar;28(1):81-117
9. Zada G, Lin N, Ojerholm E, Ramkissoon S et al. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010 Apr;28(4):E4
10. Kanter AS, Sansur CA, Jane Jr JA, Laws Jr ER. Rathke’s cleft cysts. Front Horm Res.2006. 34:127-157
11. Black PM, Hsu DW, Klibanski A, Kliman B et al. Hormone production in clinically nonfunctioning pituitary adenomas. J neurosurg. 1987. 66:244-250
12. Esiri MM, Adams CB, Burke C. Pituitary adenomas: immunohistology and ultrastructural analysis of 118 tumors. Acta Neuropathol. 1983;62(1-2):1-14.
13. Al-Shraim M, Asa SL The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol. 2006.111:1-7
14. Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am. 2008. 37:151-171
15. Wolpert SM, Molitch ME, Goldman JA, Wood JB. Size, shape, and appearance of the normal female pituitary gland. AJR Am J Roentgenol. 1984 Aug;143(2):377-81.
16. Chambers EF, Turski PA, LaMasters D, Newton TH. Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology.1982. 144:109-113
17. Peyster RG, Adler LP, Viscarello RR, Hoover ED et al. CT of the normal pituitary gland. Neuroradiology .1986. 28:161-165
18. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med.1994. 120:817-820
19. Nammour GM, Ybarra J, Naheedy MH, Romeo JH et al. Incidental pituitary macroadenoma: a population- based study. Am J Med Sci. 1997 Nov;314(5):287-91.
20. Yue NC, Longstreth WT, Elster AD, Jungreis CA et al. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health study. Radiology. 1997. 202:41-46
21. Igarashi T, Saeki N, Yamaura A. Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors— their natural history and surgical indications. Neurol Med Chir (Tokyo).1999. 39:592-598; discussion 598-599
22. Karavitaki N, Collison K, Halliday J, Byrne JV et al. What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin endocrinol (Oxf). 2007. 67:938-943
23. Dekkers OM, Hammer S, deKeizer RJ, Roelfsema F et al. The natural course of nonfunctioning pituitary macroadenomas. Eur J. endocrinol.2007.156:217-224
24. Nishizawa S, Ohta S, Yokoyama T, Uemura K. Therapeutic strategy for incidentally found pituitary tumors (“pituitary incidentalomas”). Neurosurgery .1998. 43:1344-1348
25. Daly AF, Rixhon M, Adam C, Dempegioti A et al. High prevalence of pituitary adenomas: a crosssectional study in the province of liege, Belgium. J Clin endocrinol Metab. 2006. 91:4769-4775
26. Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a communitybased, cross-sectional study in Banbury (Oxfordshire, uK). Clin endocrinol (Oxf) 72:377-382
27. Raappana A, Koivukangas J, Ebeling T, Pirila T. Incidence of pituitary adenomas in northern Finland in 1992-2007. J Clin endocrinol Metab. 2010. 95:4268-4275
28. Buurman H, Saeger W. subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J. endocrinol. 2006.154:753-758
29. Casanueva FF, Molitch ME, Schlechte JA, Abs R et al. Guidelines of the Pituitary society for the diagnosis and management of prolactinomas. Clin endocrinol (Oxf). 2006. 65:265-273
30. Angeli A, Terzolo M. Adrenal incidentaloma — a modern disease with old complications. J Clin endocrinol Metab. 2002. 87:4869-4871
31. Nieman LK, Biller BM, Findling JW, Newell-Price J et al. The diagnosis of Cushing’s syndrome: an endocrine society Clinical Practice Guideline. J Clin endocrinol Metab. 2008. 93:1526-1540
32. Karavitaki N, Ansorge O, Wass JA. Silent corticotroph adenomas. Arq. Bras. Endocrinol Metabol. 2007. 51:1314-1318
33. Yuen KC, Cook DM, Sahasranam P, Patel P et al. Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum iGF-1 levels. Clin endocrinol (Oxf). 2008. 69:292-298
34. Molitch ME, Clemmons DR, Malozowski S, Merriam GR et al. Evaluation and treatment of adult growth hormone deficiency: an endocrine society Clinical Practice Guideline. J Clin endocrinol Metab. 2006. 91:1621-1634
35. Gruber A, Clayton J, Kumar S, Robertson I et al. Pituitary apoplexy: retrospective review of 30 patients—is surgical intervention always necessary? Br J Neurosurg. 2006. 20:379385